Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
BACKGROUND AND OBJECTIVE: Tuberculosis is the most dangerous infectious disease in the world today. Rifampicin (RMP) and Isoniazid (INH) are the two most important first-line anti-tuberculosis drugs for the treatment of tuberculosis. Resistance to these drugs has been increased in most of countries....
Guardado en:
Autores principales: | M Pourhajibagher, M Nasrollahi, SR Musavi, B Rahimi-Esboei, A Ghorbani Pashakolaei |
---|---|
Formato: | article |
Lenguaje: | EN FA |
Publicado: |
Babol University of Medical Sciences
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a3acb9c5a264b3f83edfd7ddaab2e28 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on Mycobacterium tuberculosis
por: Zomorodbakhsh S, et al.
Publicado: (2020) -
Detection of serum isoniazid concentration in patients with multidrug-resistant tuberculosis using high-performance liquid chromatography
por: M. K. Vinokurova, et al.
Publicado: (2018) -
How to Effectively Identify Patients With Rifampin-Resistant Tuberculosis in China: Perspectives of Stakeholders Among Service Providers
por: Qianhui Hua, et al.
Publicado: (2021) -
Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain
por: Hakkimane SS, et al.
Publicado: (2018) -
Detección de mutaciones asociadas a cepas multidrogo resistente de Mycobacterium tuberculosis en Chile
por: Araya,Pamela, et al.
Publicado: (2011)